Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
NSTG > SEC Filings for NSTG > Form 8-K on 13-Jan-2014All Recent SEC Filings

Show all filings for NANOSTRING TECHNOLOGIES INC

Form 8-K for NANOSTRING TECHNOLOGIES INC


13-Jan-2014

Regulation FD Disclosure, Change in Directors or Principal Officers,


Item 7.01 Regulation FD Disclosure

In connection with NanoString Technologies, Inc.'s participation in the JP Morgan Annual Healthcare Conference, the Company announced on January 13, 2014 its preliminary revenue and certain other results at and for the year ended December 31, 2013. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. The information in Items 2.02 and 7.01 of this Form 8-K and the attached exhibit are furnished to, but not filed with, the Securities and Exchange Commission.



Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On January 13, 2014, the compensation committee of our board of directors approved 2013 non-equity incentive plan bonuses for our named executive officers. The compensation committee also approved 2014 base salaries for each of our named executive officers. For additional information, please see the section captioned "Executive Compensation" of our Registration Statement on Form S-1 filed with the Securities and Exchange Commission on January 13, 2014.

                                                                2013 Non-
                                                               Equity Plan         2014 Base
Name                                      Title                Compensation          Salary
R. Bradley Gray                  President and Chief
                                 Executive Officer            $      228,000       $  450,000
James A. Johnson                 Chief Financial Officer             128,975          352,000
Joseph M. Beechem                Senior Vice President of
                                 Research and Development            117,425          335,000

Mr. Gray, Mr. Johnson and Dr. Beechem are eligible to receive bonuses under our 2014 non-equity incentive plan of up to 60%, 40% and 45%, respectively, of their base salary. The 2014 performance goals for these officers are related to various corporate objectives, including continued revenue growth, execution of U.S. commercial launch of Prosigna and continued international commercialization of Prosigna, continued development of next-generation nCounter Analysis System, enhanced diagnostic pipeline, effective management of organizational growth, achievement of cash position goals and other financial targets and additional stretch targets. Mr. Gray's bonus is based solely on corporate goals. Bonuses for Mr. Johnson and Dr. Beechem are based 75% on corporate goals and 25% on individual goals.



Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Pursuant to the rules and regulations of the Securities and Exchange Commission, the attached exhibit is deemed to have been furnished to, but not filed with, the Securities and Exchange Commission:

Exhibit Number Description

99.1 Press release dated January 13, 2014.


  Add NSTG to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for NSTG - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.